Cite

    Chatzis, O. et al. (2021). Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial. Clinical microbiology and infection. pp. 878-885. [Online].